Form D · Pharmaceuticals
EMBERA NEUROTHERAPEUTICS, INC.
Sudbury, MA · CIK 0001388707
Offering snapshot reported Dec 30, 2019 · SEC filing
- Reported sold
- $6.13M Offering amount: $8.28M
- Investors reported
- 70 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 19, 2019 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 30, 2019 | Amendment | $6,128,235 | $0vs Oct 2, 2019 | 70 | SEC filing |
| Oct 2, 2019 | Initial | $6,128,235 | No comparison | 70 | SEC filing |
| Sep 29, 2015 | Amendment | $4,511,399 | $2,166,110vs Jan 23, 2015 | 19 | SEC filing |
| Jan 23, 2015 | Initial | $2,345,289 | No comparison | 8 | SEC filing |
| Aug 16, 2011 | Initial | $3,505,644 | No comparison | 8 | SEC filing |
| Mar 10, 2010 | Amendment | $490,000 | $390,000vs Nov 5, 2009 | 3 | SEC filing |
| Nov 5, 2009 | Initial | $100,000 | No comparison | 1 | SEC filing |
| May 28, 2009 | Initial | $100,000 | No comparison | Not reported | SEC filing |
| May 28, 2009 | Initial | $300,000 | No comparison | Not reported | SEC filing |
| Sep 15, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 29, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $3K
- Finders' fees
- $0
- Form D file number
- 021-350179
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Witherspoon Partners | 226591 |
Source: Form D, filed Dec 30, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ross Barrett | Director |
| John Beaird | Director |
| Nicholas Goeders | Director, Executive |
| Franz Hefti | Director |
| Robert B. Linke | Director, Executive |
| Joseph Lovett | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:Sudbury, MA, 01776